nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—ADRA2A—epilepsy syndrome	0.182	0.471	CbGaD
Lisuride—HTR2A—epilepsy syndrome	0.107	0.276	CbGaD
Lisuride—CYP2D6—epilepsy syndrome	0.0978	0.253	CbGaD
Lisuride—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.015	0.0819	CbGbCtD
Lisuride—CYP3A4—Felbamate—epilepsy syndrome	0.0139	0.0761	CbGbCtD
Lisuride—CYP3A4—Trimethadione—epilepsy syndrome	0.0139	0.0761	CbGbCtD
Lisuride—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0131	0.0716	CbGbCtD
Lisuride—CYP2D6—Propofol—epilepsy syndrome	0.0124	0.0677	CbGbCtD
Lisuride—CYP3A4—Clonazepam—epilepsy syndrome	0.0119	0.0647	CbGbCtD
Lisuride—CYP3A4—Clobazam—epilepsy syndrome	0.0114	0.0621	CbGbCtD
Lisuride—CYP3A4—Rufinamide—epilepsy syndrome	0.00966	0.0528	CbGbCtD
Lisuride—CYP3A4—Carbamazepine—epilepsy syndrome	0.00941	0.0514	CbGbCtD
Lisuride—CYP3A4—Primidone—epilepsy syndrome	0.00879	0.048	CbGbCtD
Lisuride—HTR1D—meninx—epilepsy syndrome	0.00851	0.0961	CbGeAlD
Lisuride—CYP3A4—Phenytoin—epilepsy syndrome	0.00844	0.0461	CbGbCtD
Lisuride—CYP3A4—Propofol—epilepsy syndrome	0.00788	0.043	CbGbCtD
Lisuride—CYP3A4—Acetazolamide—epilepsy syndrome	0.00753	0.0411	CbGbCtD
Lisuride—CYP3A4—Phenobarbital—epilepsy syndrome	0.00753	0.0411	CbGbCtD
Lisuride—CYP3A4—Midazolam—epilepsy syndrome	0.00742	0.0405	CbGbCtD
Lisuride—CYP3A4—Diazepam—epilepsy syndrome	0.00714	0.039	CbGbCtD
Lisuride—CYP3A4—Zonisamide—epilepsy syndrome	0.00696	0.038	CbGbCtD
Lisuride—CYP3A4—Valproic Acid—epilepsy syndrome	0.00562	0.0307	CbGbCtD
Lisuride—CYP3A4—Topiramate—epilepsy syndrome	0.00507	0.0277	CbGbCtD
Lisuride—HTR2A—phrenic nerve—epilepsy syndrome	0.00458	0.0517	CbGeAlD
Lisuride—DRD3—telencephalic ventricle—epilepsy syndrome	0.00347	0.0392	CbGeAlD
Lisuride—DRD1—telencephalic ventricle—epilepsy syndrome	0.00249	0.0281	CbGeAlD
Lisuride—HTR2A—locus ceruleus—epilepsy syndrome	0.00204	0.0231	CbGeAlD
Lisuride—DRD5—ganglion—epilepsy syndrome	0.00203	0.0229	CbGeAlD
Lisuride—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00202	0.0228	CbGeAlD
Lisuride—HTR1D—telencephalic ventricle—epilepsy syndrome	0.00195	0.022	CbGeAlD
Lisuride—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00193	0.0218	CbGeAlD
Lisuride—HTR2A—cerebellar cortex—epilepsy syndrome	0.00167	0.0188	CbGeAlD
Lisuride—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00163	0.0184	CbGeAlD
Lisuride—HTR2A—vagus nerve—epilepsy syndrome	0.00156	0.0177	CbGeAlD
Lisuride—DRD1—ganglion—epilepsy syndrome	0.00155	0.0175	CbGeAlD
Lisuride—DRD2—telencephalic ventricle—epilepsy syndrome	0.00147	0.0166	CbGeAlD
Lisuride—HTR1B—ganglion—epilepsy syndrome	0.00125	0.0142	CbGeAlD
Lisuride—HTR1D—ganglion—epilepsy syndrome	0.00121	0.0137	CbGeAlD
Lisuride—HTR2C—ganglion—epilepsy syndrome	0.0012	0.0136	CbGeAlD
Lisuride—HTR2A—pons—epilepsy syndrome	0.00118	0.0133	CbGeAlD
Lisuride—HTR2A—autonomic nervous system—epilepsy syndrome	0.00109	0.0123	CbGeAlD
Lisuride—HTR1A—ganglion—epilepsy syndrome	0.00101	0.0114	CbGeAlD
Lisuride—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000969	0.0109	CbGeAlD
Lisuride—DRD2—ganglion—epilepsy syndrome	0.000915	0.0103	CbGeAlD
Lisuride—DRD5—forebrain—epilepsy syndrome	0.00085	0.0096	CbGeAlD
Lisuride—DRD5—telencephalon—epilepsy syndrome	0.000782	0.00883	CbGeAlD
Lisuride—HTR1A—hindbrain—epilepsy syndrome	0.000768	0.00867	CbGeAlD
Lisuride—DRD2—hindbrain—epilepsy syndrome	0.000694	0.00783	CbGeAlD
Lisuride—ADRA1D—forebrain—epilepsy syndrome	0.000682	0.0077	CbGeAlD
Lisuride—DRD1—brainstem—epilepsy syndrome	0.000673	0.0076	CbGeAlD
Lisuride—DRD1—forebrain—epilepsy syndrome	0.000649	0.00734	CbGeAlD
Lisuride—ADRA1D—telencephalon—epilepsy syndrome	0.000627	0.00708	CbGeAlD
Lisuride—HTR2A—ganglion—epilepsy syndrome	0.000603	0.00681	CbGeAlD
Lisuride—DRD1—telencephalon—epilepsy syndrome	0.000597	0.00674	CbGeAlD
Lisuride—Cabergoline—HTR7—epilepsy syndrome	0.000571	0.143	CrCbGaD
Lisuride—HTR1B—brainstem—epilepsy syndrome	0.000545	0.00616	CbGeAlD
Lisuride—DRD4—brain—epilepsy syndrome	0.000535	0.00605	CbGeAlD
Lisuride—HTR1D—brainstem—epilepsy syndrome	0.000528	0.00596	CbGeAlD
Lisuride—HTR1B—forebrain—epilepsy syndrome	0.000526	0.00594	CbGeAlD
Lisuride—HTR2C—brainstem—epilepsy syndrome	0.000523	0.0059	CbGeAlD
Lisuride—DRD3—head—epilepsy syndrome	0.000519	0.00587	CbGeAlD
Lisuride—HTR1D—forebrain—epilepsy syndrome	0.000509	0.00575	CbGeAlD
Lisuride—HTR2C—forebrain—epilepsy syndrome	0.000505	0.0057	CbGeAlD
Lisuride—ADRB1—forebrain—epilepsy syndrome	0.000495	0.00559	CbGeAlD
Lisuride—DRD3—nervous system—epilepsy syndrome	0.000492	0.00556	CbGeAlD
Lisuride—Cabergoline—ADRA2A—epilepsy syndrome	0.00049	0.123	CrCbGaD
Lisuride—DRD5—head—epilepsy syndrome	0.000487	0.0055	CbGeAlD
Lisuride—HTR1B—telencephalon—epilepsy syndrome	0.000484	0.00547	CbGeAlD
Lisuride—Methysergide—HTR7—epilepsy syndrome	0.000477	0.119	CrCbGaD
Lisuride—DRD3—central nervous system—epilepsy syndrome	0.000474	0.00535	CbGeAlD
Lisuride—HTR2B—forebrain—epilepsy syndrome	0.000474	0.00535	CbGeAlD
Lisuride—HTR1D—telencephalon—epilepsy syndrome	0.000468	0.00529	CbGeAlD
Lisuride—HTR2C—telencephalon—epilepsy syndrome	0.000464	0.00524	CbGeAlD
Lisuride—DRD5—nervous system—epilepsy syndrome	0.000461	0.00521	CbGeAlD
Lisuride—HTR2A—hindbrain—epilepsy syndrome	0.000458	0.00517	CbGeAlD
Lisuride—ADRB1—telencephalon—epilepsy syndrome	0.000455	0.00514	CbGeAlD
Lisuride—DRD5—central nervous system—epilepsy syndrome	0.000444	0.00502	CbGeAlD
Lisuride—HTR1A—brainstem—epilepsy syndrome	0.00044	0.00497	CbGeAlD
Lisuride—HTR2B—telencephalon—epilepsy syndrome	0.000436	0.00492	CbGeAlD
Lisuride—DRD1—midbrain—epilepsy syndrome	0.000429	0.00484	CbGeAlD
Lisuride—HTR1A—forebrain—epilepsy syndrome	0.000425	0.0048	CbGeAlD
Lisuride—CYP2D6—hindbrain—epilepsy syndrome	0.000417	0.00471	CbGeAlD
Lisuride—ADRA1B—head—epilepsy syndrome	0.000399	0.00451	CbGeAlD
Lisuride—DRD2—brainstem—epilepsy syndrome	0.000398	0.00449	CbGeAlD
Lisuride—HTR1A—telencephalon—epilepsy syndrome	0.00039	0.00441	CbGeAlD
Lisuride—ADRA1D—head—epilepsy syndrome	0.00039	0.00441	CbGeAlD
Lisuride—DRD2—forebrain—epilepsy syndrome	0.000384	0.00433	CbGeAlD
Lisuride—Pergolide—ADRA2A—epilepsy syndrome	0.000378	0.0948	CrCbGaD
Lisuride—ADRA1B—nervous system—epilepsy syndrome	0.000378	0.00427	CbGeAlD
Lisuride—DRD3—brain—epilepsy syndrome	0.000376	0.00425	CbGeAlD
Lisuride—DRD1—head—epilepsy syndrome	0.000372	0.0042	CbGeAlD
Lisuride—ADRA1D—nervous system—epilepsy syndrome	0.00037	0.00418	CbGeAlD
Lisuride—HTR2C—medulla oblongata—epilepsy syndrome	0.000365	0.00412	CbGeAlD
Lisuride—ADRA1B—central nervous system—epilepsy syndrome	0.000364	0.00411	CbGeAlD
Lisuride—ADRA1D—central nervous system—epilepsy syndrome	0.000356	0.00402	CbGeAlD
Lisuride—DRD2—telencephalon—epilepsy syndrome	0.000353	0.00398	CbGeAlD
Lisuride—DRD5—brain—epilepsy syndrome	0.000353	0.00398	CbGeAlD
Lisuride—DRD1—nervous system—epilepsy syndrome	0.000353	0.00398	CbGeAlD
Lisuride—HTR1B—midbrain—epilepsy syndrome	0.000347	0.00392	CbGeAlD
Lisuride—ADRA2C—telencephalon—epilepsy syndrome	0.000343	0.00387	CbGeAlD
Lisuride—DRD1—central nervous system—epilepsy syndrome	0.000339	0.00383	CbGeAlD
Lisuride—HTR1B—spinal cord—epilepsy syndrome	0.000339	0.00383	CbGeAlD
Lisuride—HTR1D—midbrain—epilepsy syndrome	0.000336	0.0038	CbGeAlD
Lisuride—HTR2C—midbrain—epilepsy syndrome	0.000333	0.00376	CbGeAlD
Lisuride—HTR2C—spinal cord—epilepsy syndrome	0.000325	0.00367	CbGeAlD
Lisuride—Ergotamine—ADRA2A—epilepsy syndrome	0.000316	0.0791	CrCbGaD
Lisuride—HTR1B—head—epilepsy syndrome	0.000301	0.0034	CbGeAlD
Lisuride—ADRA2A—forebrain—epilepsy syndrome	0.000298	0.00336	CbGeAlD
Lisuride—HTR1D—head—epilepsy syndrome	0.000292	0.00329	CbGeAlD
Lisuride—ADRA1B—brain—epilepsy syndrome	0.000289	0.00327	CbGeAlD
Lisuride—HTR2C—head—epilepsy syndrome	0.000289	0.00326	CbGeAlD
Lisuride—Methylergometrine—HTR2A—epilepsy syndrome	0.000287	0.072	CrCbGaD
Lisuride—Cabergoline—HTR2A—epilepsy syndrome	0.000287	0.072	CrCbGaD
Lisuride—HTR1B—nervous system—epilepsy syndrome	0.000286	0.00323	CbGeAlD
Lisuride—ADRB1—head—epilepsy syndrome	0.000283	0.0032	CbGeAlD
Lisuride—ADRA1D—brain—epilepsy syndrome	0.000283	0.00319	CbGeAlD
Lisuride—HTR1A—midbrain—epilepsy syndrome	0.00028	0.00317	CbGeAlD
Lisuride—HTR1D—nervous system—epilepsy syndrome	0.000277	0.00312	CbGeAlD
Lisuride—HTR1B—central nervous system—epilepsy syndrome	0.000275	0.00311	CbGeAlD
Lisuride—HTR2C—nervous system—epilepsy syndrome	0.000274	0.00309	CbGeAlD
Lisuride—ADRA2A—telencephalon—epilepsy syndrome	0.000274	0.00309	CbGeAlD
Lisuride—HTR1A—spinal cord—epilepsy syndrome	0.000274	0.00309	CbGeAlD
Lisuride—HTR2B—head—epilepsy syndrome	0.000271	0.00306	CbGeAlD
Lisuride—ADRA2C—medulla oblongata—epilepsy syndrome	0.00027	0.00304	CbGeAlD
Lisuride—DRD1—brain—epilepsy syndrome	0.000269	0.00304	CbGeAlD
Lisuride—ADRB1—nervous system—epilepsy syndrome	0.000269	0.00304	CbGeAlD
Lisuride—HTR1D—central nervous system—epilepsy syndrome	0.000266	0.00301	CbGeAlD
Lisuride—HTR2C—central nervous system—epilepsy syndrome	0.000264	0.00298	CbGeAlD
Lisuride—HTR2A—brainstem—epilepsy syndrome	0.000262	0.00296	CbGeAlD
Lisuride—ADRB1—central nervous system—epilepsy syndrome	0.000259	0.00292	CbGeAlD
Lisuride—HTR2B—nervous system—epilepsy syndrome	0.000257	0.00291	CbGeAlD
Lisuride—DRD2—midbrain—epilepsy syndrome	0.000253	0.00286	CbGeAlD
Lisuride—HTR2A—forebrain—epilepsy syndrome	0.000253	0.00286	CbGeAlD
Lisuride—HTR2B—central nervous system—epilepsy syndrome	0.000248	0.0028	CbGeAlD
Lisuride—ADRA2C—midbrain—epilepsy syndrome	0.000246	0.00278	CbGeAlD
Lisuride—HTR1A—head—epilepsy syndrome	0.000243	0.00275	CbGeAlD
Lisuride—ADRA2C—spinal cord—epilepsy syndrome	0.00024	0.00271	CbGeAlD
Lisuride—Methysergide—HTR2A—epilepsy syndrome	0.00024	0.0601	CrCbGaD
Lisuride—CYP2D6—brainstem—epilepsy syndrome	0.000239	0.0027	CbGeAlD
Lisuride—HTR2A—telencephalon—epilepsy syndrome	0.000233	0.00263	CbGeAlD
Lisuride—CYP2D6—forebrain—epilepsy syndrome	0.000231	0.0026	CbGeAlD
Lisuride—HTR1A—nervous system—epilepsy syndrome	0.000231	0.0026	CbGeAlD
Lisuride—HTR1A—central nervous system—epilepsy syndrome	0.000222	0.00251	CbGeAlD
Lisuride—Pergolide—HTR2A—epilepsy syndrome	0.000222	0.0556	CrCbGaD
Lisuride—DRD2—head—epilepsy syndrome	0.00022	0.00248	CbGeAlD
Lisuride—HTR1B—brain—epilepsy syndrome	0.000218	0.00247	CbGeAlD
Lisuride—HTR1A—cerebellum—epilepsy syndrome	0.000217	0.00245	CbGeAlD
Lisuride—ADRA2A—medulla oblongata—epilepsy syndrome	0.000215	0.00243	CbGeAlD
Lisuride—Ergonovine—ABCB1—epilepsy syndrome	0.000214	0.0538	CrCbGaD
Lisuride—ADRA2C—head—epilepsy syndrome	0.000214	0.00241	CbGeAlD
Lisuride—CYP2D6—telencephalon—epilepsy syndrome	0.000212	0.00239	CbGeAlD
Lisuride—HTR1D—brain—epilepsy syndrome	0.000211	0.00239	CbGeAlD
Lisuride—HTR2C—brain—epilepsy syndrome	0.000209	0.00236	CbGeAlD
Lisuride—DRD2—nervous system—epilepsy syndrome	0.000208	0.00235	CbGeAlD
Lisuride—ADRB1—brain—epilepsy syndrome	0.000205	0.00232	CbGeAlD
Lisuride—Pergolide—CYP2D6—epilepsy syndrome	0.000203	0.0509	CrCbGaD
Lisuride—ADRA2C—nervous system—epilepsy syndrome	0.000202	0.00229	CbGeAlD
Lisuride—DRD2—central nervous system—epilepsy syndrome	0.000201	0.00226	CbGeAlD
Lisuride—HTR2B—brain—epilepsy syndrome	0.000197	0.00222	CbGeAlD
Lisuride—ADRA2A—midbrain—epilepsy syndrome	0.000197	0.00222	CbGeAlD
Lisuride—DRD2—cerebellum—epilepsy syndrome	0.000196	0.00221	CbGeAlD
Lisuride—ADRA2C—central nervous system—epilepsy syndrome	0.000195	0.0022	CbGeAlD
Lisuride—ADRA2A—spinal cord—epilepsy syndrome	0.000192	0.00217	CbGeAlD
Lisuride—ADRA2C—cerebellum—epilepsy syndrome	0.000191	0.00215	CbGeAlD
Lisuride—Ergotamine—HTR2A—epilepsy syndrome	0.000185	0.0464	CrCbGaD
Lisuride—HTR2A—medulla oblongata—epilepsy syndrome	0.000183	0.00207	CbGeAlD
Lisuride—Vomiting—Clobazam—epilepsy syndrome	0.000178	0.000999	CcSEcCtD
Lisuride—Insomnia—Zonisamide—epilepsy syndrome	0.000178	0.000998	CcSEcCtD
Lisuride—Constipation—Diazepam—epilepsy syndrome	0.000178	0.000996	CcSEcCtD
Lisuride—Dry mouth—Lamotrigine—epilepsy syndrome	0.000177	0.000994	CcSEcCtD
Lisuride—Angiopathy—Valproic Acid—epilepsy syndrome	0.000176	0.000989	CcSEcCtD
Lisuride—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000176	0.000989	CcSEcCtD
Lisuride—HTR1A—brain—epilepsy syndrome	0.000176	0.00199	CbGeAlD
Lisuride—Headache—Clobazam—epilepsy syndrome	0.000176	0.000985	CcSEcCtD
Lisuride—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000176	0.000984	CcSEcCtD
Lisuride—Tachycardia—Carbamazepine—epilepsy syndrome	0.000175	0.000984	CcSEcCtD
Lisuride—Dyspnoea—Zonisamide—epilepsy syndrome	0.000175	0.000984	CcSEcCtD
Lisuride—Confusional state—Lamotrigine—epilepsy syndrome	0.000175	0.000982	CcSEcCtD
Lisuride—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000175	0.000982	CcSEcCtD
Lisuride—Somnolence—Zonisamide—epilepsy syndrome	0.000175	0.000981	CcSEcCtD
Lisuride—Hallucination—Pregabalin—epilepsy syndrome	0.000175	0.00098	CcSEcCtD
Lisuride—Decreased appetite—Felbamate—epilepsy syndrome	0.000175	0.00098	CcSEcCtD
Lisuride—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000174	0.000975	CcSEcCtD
Lisuride—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000174	0.000975	CcSEcCtD
Lisuride—Fatigue—Felbamate—epilepsy syndrome	0.000173	0.000972	CcSEcCtD
Lisuride—Oedema peripheral—Pregabalin—epilepsy syndrome	0.000173	0.00097	CcSEcCtD
Lisuride—Infection—Lamotrigine—epilepsy syndrome	0.000173	0.000968	CcSEcCtD
Lisuride—Sweating—Gabapentin—epilepsy syndrome	0.000172	0.000965	CcSEcCtD
Lisuride—Constipation—Felbamate—epilepsy syndrome	0.000172	0.000964	CcSEcCtD
Lisuride—Insomnia—Clonazepam—epilepsy syndrome	0.000172	0.000962	CcSEcCtD
Lisuride—Anorexia—Carbamazepine—epilepsy syndrome	0.000171	0.000961	CcSEcCtD
Lisuride—Feeling abnormal—Diazepam—epilepsy syndrome	0.000171	0.00096	CcSEcCtD
Lisuride—Decreased appetite—Zonisamide—epilepsy syndrome	0.000171	0.000959	CcSEcCtD
Lisuride—ADRA2A—head—epilepsy syndrome	0.00017	0.00192	CbGeAlD
Lisuride—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.00017	0.000955	CcSEcCtD
Lisuride—Insomnia—Phenytoin—epilepsy syndrome	0.00017	0.000955	CcSEcCtD
Lisuride—Mental disorder—Valproic Acid—epilepsy syndrome	0.00017	0.000955	CcSEcCtD
Lisuride—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.00017	0.000952	CcSEcCtD
Lisuride—Fatigue—Zonisamide—epilepsy syndrome	0.00017	0.000951	CcSEcCtD
Lisuride—Tachycardia—Lamotrigine—epilepsy syndrome	0.00017	0.000951	CcSEcCtD
Lisuride—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000169	0.00095	CcSEcCtD
Lisuride—Malnutrition—Valproic Acid—epilepsy syndrome	0.000169	0.000949	CcSEcCtD
Lisuride—Dyspnoea—Clonazepam—epilepsy syndrome	0.000169	0.000948	CcSEcCtD
Lisuride—Somnolence—Clonazepam—epilepsy syndrome	0.000169	0.000945	CcSEcCtD
Lisuride—Constipation—Zonisamide—epilepsy syndrome	0.000168	0.000943	CcSEcCtD
Lisuride—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000168	0.000942	CcSEcCtD
Lisuride—Dyspnoea—Phenytoin—epilepsy syndrome	0.000168	0.000942	CcSEcCtD
Lisuride—Somnolence—Phenytoin—epilepsy syndrome	0.000167	0.000939	CcSEcCtD
Lisuride—HTR2A—midbrain—epilepsy syndrome	0.000167	0.00189	CbGeAlD
Lisuride—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000167	0.000937	CcSEcCtD
Lisuride—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000167	0.000934	CcSEcCtD
Lisuride—Asthenia—Propofol—epilepsy syndrome	0.000167	0.000934	CcSEcCtD
Lisuride—Feeling abnormal—Felbamate—epilepsy syndrome	0.000166	0.000929	CcSEcCtD
Lisuride—Anorexia—Lamotrigine—epilepsy syndrome	0.000166	0.000929	CcSEcCtD
Lisuride—Dizziness—Acetazolamide—epilepsy syndrome	0.000165	0.000926	CcSEcCtD
Lisuride—Decreased appetite—Clonazepam—epilepsy syndrome	0.000165	0.000924	CcSEcCtD
Lisuride—Decreased appetite—Phenytoin—epilepsy syndrome	0.000164	0.000918	CcSEcCtD
Lisuride—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000164	0.000918	CcSEcCtD
Lisuride—Fatigue—Clonazepam—epilepsy syndrome	0.000163	0.000917	CcSEcCtD
Lisuride—Cardiac disorder—Pregabalin—epilepsy syndrome	0.000163	0.000914	CcSEcCtD
Lisuride—HTR2A—spinal cord—epilepsy syndrome	0.000163	0.00184	CbGeAlD
Lisuride—Asthenia—Midazolam—epilepsy syndrome	0.000163	0.000913	CcSEcCtD
Lisuride—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000163	0.000913	CcSEcCtD
Lisuride—Insomnia—Carbamazepine—epilepsy syndrome	0.000163	0.000912	CcSEcCtD
Lisuride—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000163	0.000912	CcSEcCtD
Lisuride—Fatigue—Phenytoin—epilepsy syndrome	0.000162	0.00091	CcSEcCtD
Lisuride—Abdominal discomfort—Topiramate—epilepsy syndrome	0.000162	0.00091	CcSEcCtD
Lisuride—Constipation—Clonazepam—epilepsy syndrome	0.000162	0.000909	CcSEcCtD
Lisuride—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000162	0.000909	CcSEcCtD
Lisuride—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000162	0.000907	CcSEcCtD
Lisuride—ADRA2A—nervous system—epilepsy syndrome	0.000162	0.00182	CbGeAlD
Lisuride—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000162	0.000906	CcSEcCtD
Lisuride—Constipation—Phenytoin—epilepsy syndrome	0.000161	0.000903	CcSEcCtD
Lisuride—Asthenia—Levetiracetam—epilepsy syndrome	0.000161	0.000902	CcSEcCtD
Lisuride—Hallucination—Gabapentin—epilepsy syndrome	0.00016	0.000899	CcSEcCtD
Lisuride—Dyspnoea—Carbamazepine—epilepsy syndrome	0.00016	0.000899	CcSEcCtD
Lisuride—Constipation—Oxcarbazepine—epilepsy syndrome	0.00016	0.000898	CcSEcCtD
Lisuride—Somnolence—Carbamazepine—epilepsy syndrome	0.00016	0.000896	CcSEcCtD
Lisuride—Angiopathy—Pregabalin—epilepsy syndrome	0.000159	0.000894	CcSEcCtD
Lisuride—DRD2—brain—epilepsy syndrome	0.000159	0.0018	CbGeAlD
Lisuride—Vomiting—Acetazolamide—epilepsy syndrome	0.000159	0.000891	CcSEcCtD
Lisuride—Oedema peripheral—Gabapentin—epilepsy syndrome	0.000159	0.00089	CcSEcCtD
Lisuride—Immune system disorder—Pregabalin—epilepsy syndrome	0.000159	0.00089	CcSEcCtD
Lisuride—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000158	0.000888	CcSEcCtD
Lisuride—Insomnia—Lamotrigine—epilepsy syndrome	0.000157	0.000881	CcSEcCtD
Lisuride—Headache—Acetazolamide—epilepsy syndrome	0.000157	0.000878	CcSEcCtD
Lisuride—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000156	0.000876	CcSEcCtD
Lisuride—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000156	0.000876	CcSEcCtD
Lisuride—ADRA2A—central nervous system—epilepsy syndrome	0.000156	0.00176	CbGeAlD
Lisuride—Asthenia—Fosphenytoin—epilepsy syndrome	0.000155	0.000871	CcSEcCtD
Lisuride—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000155	0.00087	CcSEcCtD
Lisuride—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000155	0.00087	CcSEcCtD
Lisuride—Fatigue—Carbamazepine—epilepsy syndrome	0.000155	0.000869	CcSEcCtD
Lisuride—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000155	0.000869	CcSEcCtD
Lisuride—ADRA2C—brain—epilepsy syndrome	0.000155	0.00175	CbGeAlD
Lisuride—Somnolence—Lamotrigine—epilepsy syndrome	0.000154	0.000866	CcSEcCtD
Lisuride—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000154	0.000866	CcSEcCtD
Lisuride—Weight increased—Topiramate—epilepsy syndrome	0.000154	0.000864	CcSEcCtD
Lisuride—Mental disorder—Pregabalin—epilepsy syndrome	0.000154	0.000863	CcSEcCtD
Lisuride—Constipation—Carbamazepine—epilepsy syndrome	0.000154	0.000862	CcSEcCtD
Lisuride—Dizziness—Propofol—epilepsy syndrome	0.000153	0.000861	CcSEcCtD
Lisuride—Weight decreased—Topiramate—epilepsy syndrome	0.000153	0.000859	CcSEcCtD
Lisuride—Malnutrition—Pregabalin—epilepsy syndrome	0.000153	0.000858	CcSEcCtD
Lisuride—ADRA2A—cerebellum—epilepsy syndrome	0.000152	0.00172	CbGeAlD
Lisuride—Vertigo—Valproic Acid—epilepsy syndrome	0.000152	0.000852	CcSEcCtD
Lisuride—Asthenia—Vigabatrin—epilepsy syndrome	0.000151	0.000849	CcSEcCtD
Lisuride—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000151	0.000847	CcSEcCtD
Lisuride—Dizziness—Midazolam—epilepsy syndrome	0.00015	0.000842	CcSEcCtD
Lisuride—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.00015	0.000841	CcSEcCtD
Lisuride—Fatigue—Lamotrigine—epilepsy syndrome	0.00015	0.00084	CcSEcCtD
Lisuride—Cardiac disorder—Gabapentin—epilepsy syndrome	0.00015	0.000838	CcSEcCtD
Lisuride—Palpitations—Valproic Acid—epilepsy syndrome	0.00015	0.000838	CcSEcCtD
Lisuride—Asthenia—Diazepam—epilepsy syndrome	0.000149	0.000835	CcSEcCtD
Lisuride—Constipation—Lamotrigine—epilepsy syndrome	0.000149	0.000833	CcSEcCtD
Lisuride—Dizziness—Levetiracetam—epilepsy syndrome	0.000148	0.000831	CcSEcCtD
Lisuride—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000148	0.000831	CcSEcCtD
Lisuride—Cough—Valproic Acid—epilepsy syndrome	0.000148	0.000828	CcSEcCtD
Lisuride—Vomiting—Propofol—epilepsy syndrome	0.000148	0.000827	CcSEcCtD
Lisuride—Immune system disorder—Gabapentin—epilepsy syndrome	0.000146	0.000816	CcSEcCtD
Lisuride—Headache—Propofol—epilepsy syndrome	0.000145	0.000815	CcSEcCtD
Lisuride—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000145	0.000814	CcSEcCtD
Lisuride—HTR2A—head—epilepsy syndrome	0.000145	0.00164	CbGeAlD
Lisuride—Vomiting—Midazolam—epilepsy syndrome	0.000144	0.000809	CcSEcCtD
Lisuride—Asthenia—Felbamate—epilepsy syndrome	0.000144	0.000809	CcSEcCtD
Lisuride—Anxiety—Valproic Acid—epilepsy syndrome	0.000144	0.000805	CcSEcCtD
Lisuride—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000143	0.000803	CcSEcCtD
Lisuride—Dizziness—Fosphenytoin—epilepsy syndrome	0.000143	0.000802	CcSEcCtD
Lisuride—Vomiting—Levetiracetam—epilepsy syndrome	0.000143	0.000799	CcSEcCtD
Lisuride—Headache—Midazolam—epilepsy syndrome	0.000142	0.000798	CcSEcCtD
Lisuride—Asthenia—Zonisamide—epilepsy syndrome	0.000141	0.000791	CcSEcCtD
Lisuride—Mental disorder—Gabapentin—epilepsy syndrome	0.000141	0.000791	CcSEcCtD
Lisuride—Dry mouth—Valproic Acid—epilepsy syndrome	0.000141	0.00079	CcSEcCtD
Lisuride—Headache—Levetiracetam—epilepsy syndrome	0.00014	0.000788	CcSEcCtD
Lisuride—Malnutrition—Gabapentin—epilepsy syndrome	0.00014	0.000786	CcSEcCtD
Lisuride—Dizziness—Vigabatrin—epilepsy syndrome	0.000139	0.000782	CcSEcCtD
Lisuride—Confusional state—Valproic Acid—epilepsy syndrome	0.000139	0.000781	CcSEcCtD
Lisuride—Vomiting—Fosphenytoin—epilepsy syndrome	0.000138	0.000772	CcSEcCtD
Lisuride—Vertigo—Pregabalin—epilepsy syndrome	0.000137	0.00077	CcSEcCtD
Lisuride—HTR2A—nervous system—epilepsy syndrome	0.000137	0.00155	CbGeAlD
Lisuride—Dizziness—Diazepam—epilepsy syndrome	0.000137	0.00077	CcSEcCtD
Lisuride—Infection—Valproic Acid—epilepsy syndrome	0.000137	0.000769	CcSEcCtD
Lisuride—Syncope—Pregabalin—epilepsy syndrome	0.000137	0.000769	CcSEcCtD
Lisuride—Asthenia—Clonazepam—epilepsy syndrome	0.000136	0.000763	CcSEcCtD
Lisuride—Headache—Fosphenytoin—epilepsy syndrome	0.000136	0.00076	CcSEcCtD
Lisuride—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000135	0.000759	CcSEcCtD
Lisuride—Palpitations—Pregabalin—epilepsy syndrome	0.000135	0.000758	CcSEcCtD
Lisuride—Asthenia—Phenytoin—epilepsy syndrome	0.000135	0.000758	CcSEcCtD
Lisuride—Hallucination—Topiramate—epilepsy syndrome	0.000135	0.000756	CcSEcCtD
Lisuride—Tachycardia—Valproic Acid—epilepsy syndrome	0.000135	0.000756	CcSEcCtD
Lisuride—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000134	0.000754	CcSEcCtD
Lisuride—Vomiting—Vigabatrin—epilepsy syndrome	0.000134	0.000752	CcSEcCtD
Lisuride—Oedema peripheral—Topiramate—epilepsy syndrome	0.000134	0.000749	CcSEcCtD
Lisuride—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000133	0.000748	CcSEcCtD
Lisuride—Cough—Pregabalin—epilepsy syndrome	0.000133	0.000748	CcSEcCtD
Lisuride—Dizziness—Felbamate—epilepsy syndrome	0.000133	0.000745	CcSEcCtD
Lisuride—HTR2A—central nervous system—epilepsy syndrome	0.000132	0.00149	CbGeAlD
Lisuride—Headache—Vigabatrin—epilepsy syndrome	0.000132	0.000741	CcSEcCtD
Lisuride—Vomiting—Diazepam—epilepsy syndrome	0.000132	0.00074	CcSEcCtD
Lisuride—CYP2D6—head—epilepsy syndrome	0.000132	0.00149	CbGeAlD
Lisuride—Anorexia—Valproic Acid—epilepsy syndrome	0.000132	0.000738	CcSEcCtD
Lisuride—Dizziness—Zonisamide—epilepsy syndrome	0.00013	0.000729	CcSEcCtD
Lisuride—Headache—Diazepam—epilepsy syndrome	0.00013	0.000729	CcSEcCtD
Lisuride—Anxiety—Pregabalin—epilepsy syndrome	0.00013	0.000728	CcSEcCtD
Lisuride—HTR2A—cerebellum—epilepsy syndrome	0.000129	0.00146	CbGeAlD
Lisuride—Asthenia—Carbamazepine—epilepsy syndrome	0.000129	0.000723	CcSEcCtD
Lisuride—Vomiting—Felbamate—epilepsy syndrome	0.000128	0.000717	CcSEcCtD
Lisuride—Dry mouth—Pregabalin—epilepsy syndrome	0.000127	0.000714	CcSEcCtD
Lisuride—CYP3A4—nervous system—epilepsy syndrome	0.000127	0.00144	CbGeAlD
Lisuride—Vertigo—Gabapentin—epilepsy syndrome	0.000126	0.000707	CcSEcCtD
Lisuride—Headache—Felbamate—epilepsy syndrome	0.000126	0.000706	CcSEcCtD
Lisuride—Confusional state—Pregabalin—epilepsy syndrome	0.000126	0.000706	CcSEcCtD
Lisuride—Cardiac disorder—Topiramate—epilepsy syndrome	0.000126	0.000705	CcSEcCtD
Lisuride—Syncope—Gabapentin—epilepsy syndrome	0.000126	0.000705	CcSEcCtD
Lisuride—Dizziness—Clonazepam—epilepsy syndrome	0.000125	0.000703	CcSEcCtD
Lisuride—CYP2D6—nervous system—epilepsy syndrome	0.000125	0.00141	CbGeAlD
Lisuride—Vomiting—Zonisamide—epilepsy syndrome	0.000125	0.000701	CcSEcCtD
Lisuride—Insomnia—Valproic Acid—epilepsy syndrome	0.000125	0.0007	CcSEcCtD
Lisuride—Asthenia—Lamotrigine—epilepsy syndrome	0.000125	0.000699	CcSEcCtD
Lisuride—Dizziness—Phenytoin—epilepsy syndrome	0.000125	0.000698	CcSEcCtD
Lisuride—Infection—Pregabalin—epilepsy syndrome	0.000124	0.000695	CcSEcCtD
Lisuride—Palpitations—Gabapentin—epilepsy syndrome	0.000124	0.000695	CcSEcCtD
Lisuride—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000124	0.000695	CcSEcCtD
Lisuride—ADRA2A—brain—epilepsy syndrome	0.000124	0.00139	CbGeAlD
Lisuride—Headache—Zonisamide—epilepsy syndrome	0.000123	0.000691	CcSEcCtD
Lisuride—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000123	0.00069	CcSEcCtD
Lisuride—Angiopathy—Topiramate—epilepsy syndrome	0.000123	0.00069	CcSEcCtD
Lisuride—Somnolence—Valproic Acid—epilepsy syndrome	0.000123	0.000688	CcSEcCtD
Lisuride—CYP3A4—central nervous system—epilepsy syndrome	0.000122	0.00138	CbGeAlD
Lisuride—Immune system disorder—Topiramate—epilepsy syndrome	0.000122	0.000686	CcSEcCtD
Lisuride—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000122	0.000686	CcSEcCtD
Lisuride—Cough—Gabapentin—epilepsy syndrome	0.000122	0.000686	CcSEcCtD
Lisuride—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000122	0.000685	CcSEcCtD
Lisuride—Tachycardia—Pregabalin—epilepsy syndrome	0.000122	0.000683	CcSEcCtD
Lisuride—Ergotamine—ABCB1—epilepsy syndrome	0.000121	0.0303	CrCbGaD
Lisuride—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000121	0.000677	CcSEcCtD
Lisuride—Vomiting—Clonazepam—epilepsy syndrome	0.000121	0.000676	CcSEcCtD
Lisuride—CYP2D6—central nervous system—epilepsy syndrome	0.000121	0.00136	CbGeAlD
Lisuride—Decreased appetite—Valproic Acid—epilepsy syndrome	0.00012	0.000673	CcSEcCtD
Lisuride—Vomiting—Phenytoin—epilepsy syndrome	0.00012	0.000671	CcSEcCtD
Lisuride—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000119	0.000668	CcSEcCtD
Lisuride—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000119	0.000668	CcSEcCtD
Lisuride—Fatigue—Valproic Acid—epilepsy syndrome	0.000119	0.000667	CcSEcCtD
Lisuride—Anxiety—Gabapentin—epilepsy syndrome	0.000119	0.000667	CcSEcCtD
Lisuride—Anorexia—Pregabalin—epilepsy syndrome	0.000119	0.000667	CcSEcCtD
Lisuride—Dizziness—Carbamazepine—epilepsy syndrome	0.000119	0.000667	CcSEcCtD
Lisuride—Headache—Clonazepam—epilepsy syndrome	0.000119	0.000666	CcSEcCtD
Lisuride—Mental disorder—Topiramate—epilepsy syndrome	0.000119	0.000666	CcSEcCtD
Lisuride—Constipation—Valproic Acid—epilepsy syndrome	0.000118	0.000662	CcSEcCtD
Lisuride—Headache—Phenytoin—epilepsy syndrome	0.000118	0.000662	CcSEcCtD
Lisuride—Malnutrition—Topiramate—epilepsy syndrome	0.000118	0.000662	CcSEcCtD
Lisuride—CYP2D6—cerebellum—epilepsy syndrome	0.000118	0.00133	CbGeAlD
Lisuride—Headache—Oxcarbazepine—epilepsy syndrome	0.000117	0.000658	CcSEcCtD
Lisuride—Dry mouth—Gabapentin—epilepsy syndrome	0.000117	0.000655	CcSEcCtD
Lisuride—Confusional state—Gabapentin—epilepsy syndrome	0.000115	0.000647	CcSEcCtD
Lisuride—Dizziness—Lamotrigine—epilepsy syndrome	0.000115	0.000644	CcSEcCtD
Lisuride—Vomiting—Carbamazepine—epilepsy syndrome	0.000114	0.000641	CcSEcCtD
Lisuride—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000114	0.000638	CcSEcCtD
Lisuride—Infection—Gabapentin—epilepsy syndrome	0.000114	0.000638	CcSEcCtD
Lisuride—Insomnia—Pregabalin—epilepsy syndrome	0.000113	0.000633	CcSEcCtD
Lisuride—Headache—Carbamazepine—epilepsy syndrome	0.000113	0.000632	CcSEcCtD
Lisuride—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000112	0.000629	CcSEcCtD
Lisuride—Tachycardia—Gabapentin—epilepsy syndrome	0.000112	0.000626	CcSEcCtD
Lisuride—Dyspnoea—Pregabalin—epilepsy syndrome	0.000111	0.000624	CcSEcCtD
Lisuride—Somnolence—Pregabalin—epilepsy syndrome	0.000111	0.000622	CcSEcCtD
Lisuride—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000111	0.00062	CcSEcCtD
Lisuride—Vomiting—Lamotrigine—epilepsy syndrome	0.00011	0.000619	CcSEcCtD
Lisuride—Anorexia—Gabapentin—epilepsy syndrome	0.000109	0.000612	CcSEcCtD
Lisuride—Headache—Lamotrigine—epilepsy syndrome	0.000109	0.00061	CcSEcCtD
Lisuride—Decreased appetite—Pregabalin—epilepsy syndrome	0.000109	0.000608	CcSEcCtD
Lisuride—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000108	0.000604	CcSEcCtD
Lisuride—Fatigue—Pregabalin—epilepsy syndrome	0.000108	0.000603	CcSEcCtD
Lisuride—Constipation—Pregabalin—epilepsy syndrome	0.000107	0.000599	CcSEcCtD
Lisuride—Vertigo—Topiramate—epilepsy syndrome	0.000106	0.000594	CcSEcCtD
Lisuride—Syncope—Topiramate—epilepsy syndrome	0.000106	0.000593	CcSEcCtD
Lisuride—HTR2A—brain—epilepsy syndrome	0.000105	0.00119	CbGeAlD
Lisuride—Palpitations—Topiramate—epilepsy syndrome	0.000104	0.000585	CcSEcCtD
Lisuride—Insomnia—Gabapentin—epilepsy syndrome	0.000104	0.00058	CcSEcCtD
Lisuride—Cough—Topiramate—epilepsy syndrome	0.000103	0.000577	CcSEcCtD
Lisuride—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000103	0.000577	CcSEcCtD
Lisuride—Dyspnoea—Gabapentin—epilepsy syndrome	0.000102	0.000572	CcSEcCtD
Lisuride—Somnolence—Gabapentin—epilepsy syndrome	0.000102	0.000571	CcSEcCtD
Lisuride—Anxiety—Topiramate—epilepsy syndrome	0.0001	0.000561	CcSEcCtD
Lisuride—Decreased appetite—Gabapentin—epilepsy syndrome	9.95e-05	0.000558	CcSEcCtD
Lisuride—Asthenia—Valproic Acid—epilepsy syndrome	9.91e-05	0.000555	CcSEcCtD
Lisuride—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.88e-05	0.000554	CcSEcCtD
Lisuride—Fatigue—Gabapentin—epilepsy syndrome	9.87e-05	0.000553	CcSEcCtD
Lisuride—Dry mouth—Topiramate—epilepsy syndrome	9.82e-05	0.000551	CcSEcCtD
Lisuride—Constipation—Gabapentin—epilepsy syndrome	9.79e-05	0.000549	CcSEcCtD
Lisuride—Confusional state—Topiramate—epilepsy syndrome	9.71e-05	0.000544	CcSEcCtD
Lisuride—Infection—Topiramate—epilepsy syndrome	9.57e-05	0.000536	CcSEcCtD
Lisuride—CYP2D6—brain—epilepsy syndrome	9.57e-05	0.00108	CbGeAlD
Lisuride—Nervous system disorder—Topiramate—epilepsy syndrome	9.44e-05	0.00053	CcSEcCtD
Lisuride—Feeling abnormal—Gabapentin—epilepsy syndrome	9.43e-05	0.000529	CcSEcCtD
Lisuride—Tachycardia—Topiramate—epilepsy syndrome	9.4e-05	0.000527	CcSEcCtD
Lisuride—Hyperhidrosis—Topiramate—epilepsy syndrome	9.31e-05	0.000522	CcSEcCtD
Lisuride—Anorexia—Topiramate—epilepsy syndrome	9.18e-05	0.000515	CcSEcCtD
Lisuride—Dizziness—Valproic Acid—epilepsy syndrome	9.13e-05	0.000512	CcSEcCtD
Lisuride—Asthenia—Pregabalin—epilepsy syndrome	8.96e-05	0.000502	CcSEcCtD
Lisuride—Vomiting—Valproic Acid—epilepsy syndrome	8.78e-05	0.000492	CcSEcCtD
Lisuride—Insomnia—Topiramate—epilepsy syndrome	8.71e-05	0.000488	CcSEcCtD
Lisuride—Headache—Valproic Acid—epilepsy syndrome	8.65e-05	0.000485	CcSEcCtD
Lisuride—Dyspnoea—Topiramate—epilepsy syndrome	8.59e-05	0.000481	CcSEcCtD
Lisuride—Somnolence—Topiramate—epilepsy syndrome	8.56e-05	0.00048	CcSEcCtD
Lisuride—Decreased appetite—Topiramate—epilepsy syndrome	8.37e-05	0.000469	CcSEcCtD
Lisuride—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.31e-05	0.000466	CcSEcCtD
Lisuride—Fatigue—Topiramate—epilepsy syndrome	8.3e-05	0.000466	CcSEcCtD
Lisuride—Dizziness—Pregabalin—epilepsy syndrome	8.25e-05	0.000463	CcSEcCtD
Lisuride—Constipation—Topiramate—epilepsy syndrome	8.24e-05	0.000462	CcSEcCtD
Lisuride—Asthenia—Gabapentin—epilepsy syndrome	8.21e-05	0.00046	CcSEcCtD
Lisuride—Vomiting—Pregabalin—epilepsy syndrome	7.94e-05	0.000445	CcSEcCtD
Lisuride—Feeling abnormal—Topiramate—epilepsy syndrome	7.94e-05	0.000445	CcSEcCtD
Lisuride—Headache—Pregabalin—epilepsy syndrome	7.82e-05	0.000438	CcSEcCtD
Lisuride—Dizziness—Gabapentin—epilepsy syndrome	7.57e-05	0.000424	CcSEcCtD
Lisuride—Vomiting—Gabapentin—epilepsy syndrome	7.28e-05	0.000408	CcSEcCtD
Lisuride—Headache—Gabapentin—epilepsy syndrome	7.17e-05	0.000402	CcSEcCtD
Lisuride—Asthenia—Topiramate—epilepsy syndrome	6.91e-05	0.000387	CcSEcCtD
Lisuride—Dizziness—Topiramate—epilepsy syndrome	6.37e-05	0.000357	CcSEcCtD
Lisuride—Vomiting—Topiramate—epilepsy syndrome	6.12e-05	0.000343	CcSEcCtD
Lisuride—Headache—Topiramate—epilepsy syndrome	6.03e-05	0.000338	CcSEcCtD
Lisuride—DRD4—Signaling Pathways—RELA—epilepsy syndrome	2.2e-06	1.38e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	2.19e-06	1.38e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	2.19e-06	1.38e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ALB—epilepsy syndrome	2.19e-06	1.38e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.17e-06	1.36e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	2.17e-06	1.36e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	2.17e-06	1.36e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.16e-06	1.36e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.16e-06	1.36e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	2.16e-06	1.36e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MTOR—epilepsy syndrome	2.16e-06	1.36e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	2.15e-06	1.35e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	2.14e-06	1.35e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	2.13e-06	1.34e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	2.13e-06	1.34e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	2.13e-06	1.34e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	2.12e-06	1.34e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.12e-06	1.33e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	2.1e-06	1.32e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	2.1e-06	1.32e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	2.1e-06	1.32e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	2.1e-06	1.32e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	2.08e-06	1.31e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	2.08e-06	1.31e-05	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	2.08e-06	1.31e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2.08e-06	1.31e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	2.07e-06	1.31e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	2.06e-06	1.3e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	2.06e-06	1.3e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	2.06e-06	1.3e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	2.04e-06	1.29e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	2.04e-06	1.28e-05	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.03e-06	1.28e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	2.03e-06	1.28e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	2.02e-06	1.27e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	2.01e-06	1.27e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	2.01e-06	1.26e-05	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	2e-06	1.26e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	2e-06	1.26e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2e-06	1.26e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	1.99e-06	1.25e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	1.98e-06	1.25e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—RELA—epilepsy syndrome	1.98e-06	1.25e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.97e-06	1.24e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.97e-06	1.24e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	1.96e-06	1.24e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.96e-06	1.23e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	1.96e-06	1.23e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	1.95e-06	1.23e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—RELA—epilepsy syndrome	1.95e-06	1.23e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.95e-06	1.23e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	1.94e-06	1.22e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	1.94e-06	1.22e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.94e-06	1.22e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.94e-06	1.22e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.94e-06	1.22e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.93e-06	1.22e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.93e-06	1.21e-05	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.93e-06	1.21e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—JUN—epilepsy syndrome	1.93e-06	1.21e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	1.92e-06	1.21e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	1.91e-06	1.21e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	1.91e-06	1.21e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	1.91e-06	1.2e-05	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.91e-06	1.2e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	1.9e-06	1.2e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.9e-06	1.2e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	1.9e-06	1.2e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.9e-06	1.19e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	1.89e-06	1.19e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.89e-06	1.19e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.89e-06	1.19e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.88e-06	1.18e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	1.87e-06	1.18e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.86e-06	1.17e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.85e-06	1.17e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.85e-06	1.16e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	1.84e-06	1.16e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.83e-06	1.15e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.82e-06	1.15e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—POMC—epilepsy syndrome	1.82e-06	1.15e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	1.82e-06	1.14e-05	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.8e-06	1.13e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	1.79e-06	1.13e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.79e-06	1.13e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	1.79e-06	1.13e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.79e-06	1.13e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	1.78e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.78e-06	1.12e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	1.78e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	1.78e-06	1.12e-05	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.78e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.78e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.78e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	1.77e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	1.76e-06	1.11e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	1.76e-06	1.11e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	1.76e-06	1.11e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	1.76e-06	1.11e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.75e-06	1.1e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.75e-06	1.1e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	1.75e-06	1.1e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	1.74e-06	1.1e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.73e-06	1.09e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—JUN—epilepsy syndrome	1.73e-06	1.09e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	1.73e-06	1.09e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—SRC—epilepsy syndrome	1.73e-06	1.09e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.72e-06	1.08e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	1.71e-06	1.08e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—JUN—epilepsy syndrome	1.71e-06	1.08e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.71e-06	1.08e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.7e-06	1.07e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.69e-06	1.07e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.69e-06	1.07e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	1.69e-06	1.06e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	1.68e-06	1.06e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.67e-06	1.05e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	1.66e-06	1.05e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	1.66e-06	1.05e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.66e-06	1.05e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	1.65e-06	1.04e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	1.65e-06	1.04e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	1.64e-06	1.03e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.63e-06	1.03e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.62e-06	1.02e-05	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.62e-06	1.02e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	1.61e-06	1.02e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.61e-06	1.02e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	1.61e-06	1.02e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.61e-06	1.02e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.61e-06	1.01e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.61e-06	1.01e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.61e-06	1.01e-05	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.6e-06	1.01e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-06	1.01e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.59e-06	1e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	1.59e-06	1e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.59e-06	1e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.58e-06	9.97e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	1.56e-06	9.81e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—SRC—epilepsy syndrome	1.56e-06	9.79e-06	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.55e-06	9.79e-06	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.55e-06	9.76e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	1.54e-06	9.73e-06	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.54e-06	9.7e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.53e-06	9.67e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—SRC—epilepsy syndrome	1.53e-06	9.66e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	1.53e-06	9.66e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.53e-06	9.65e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	1.53e-06	9.62e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	1.52e-06	9.55e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.52e-06	9.54e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	1.51e-06	9.54e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—TH—epilepsy syndrome	1.51e-06	9.51e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.51e-06	9.5e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	1.5e-06	9.46e-06	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.5e-06	9.44e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.49e-06	9.41e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	1.49e-06	9.41e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.49e-06	9.41e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.49e-06	9.39e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	1.49e-06	9.35e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	1.48e-06	9.34e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.48e-06	9.31e-06	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.48e-06	9.29e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-06	9.26e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	1.47e-06	9.26e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.47e-06	9.23e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	1.46e-06	9.2e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.46e-06	9.18e-06	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	1.45e-06	9.16e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.45e-06	9.13e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	1.44e-06	9.09e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	1.44e-06	9.08e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	1.44e-06	9.08e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.44e-06	9.07e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	1.42e-06	8.94e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.41e-06	8.86e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	1.4e-06	8.84e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.4e-06	8.81e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	1.4e-06	8.8e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	1.39e-06	8.72e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	1.38e-06	8.7e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	8.57e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.36e-06	8.57e-06	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.36e-06	8.56e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.35e-06	8.5e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.35e-06	8.49e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	1.34e-06	8.44e-06	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.34e-06	8.43e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.34e-06	8.42e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.34e-06	8.42e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	1.33e-06	8.38e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	1.33e-06	8.35e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.31e-06	8.26e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.31e-06	8.24e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.3e-06	8.2e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.3e-06	8.16e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	1.29e-06	8.15e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	1.29e-06	8.11e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	1.27e-06	8.02e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.27e-06	8.02e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.27e-06	8e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.26e-06	7.94e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.26e-06	7.94e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	1.25e-06	7.89e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.24e-06	7.83e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	1.24e-06	7.81e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.24e-06	7.78e-06	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.22e-06	7.67e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.22e-06	7.65e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.21e-06	7.62e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.21e-06	7.6e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.17e-06	7.39e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.17e-06	7.38e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.16e-06	7.29e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.16e-06	7.27e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.14e-06	7.2e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.14e-06	7.18e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.13e-06	7.09e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.12e-06	7.08e-06	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	1.11e-06	7.02e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.11e-06	6.96e-06	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	1.09e-06	6.87e-06	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	1.07e-06	6.76e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.05e-06	6.62e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-06	6.45e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.02e-06	6.45e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	6.38e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AGT—epilepsy syndrome	9.86e-07	6.21e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	9.66e-07	6.09e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.66e-07	6.09e-06	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—AKT1—epilepsy syndrome	9.62e-07	6.06e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	9.54e-07	6e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	9.54e-07	6e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	8.69e-07	5.47e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	8.61e-07	5.42e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	8.31e-07	5.23e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.3e-07	5.23e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	8.27e-07	5.21e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	8.04e-07	5.06e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	7.91e-07	4.98e-06	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—AKT1—epilepsy syndrome	7.81e-07	4.92e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.57e-07	4.77e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	7.3e-07	4.59e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	7.18e-07	4.52e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.62e-07	4.17e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	6.53e-07	4.11e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.09e-07	3.21e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.33e-07	2.1e-06	CbGpPWpGaD
